Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. - Wikidata - wikimedia - TriplyDB

Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.

Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.

http://www.wikidata.org/entity/Q33219958

about

Proper application of antibodies for immunohistochemical detection: antibody crimes and how to prevent them Disordered follicle development Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Characterization of functionally typical and atypical types of polycystic ovary syndrome.Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone.Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.The physiology and clinical utility of anti-Mullerian hormone in women.Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.Association study of four key folliculogenesis genes in polycystic ovary syndrome.Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome Genome wide analysis of fertility and production traits in Italian Holstein cattle.Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis.The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.Alternative splicing of the androgen receptor in polycystic ovary syndrome.Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome.Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?Ontogeny of the ovary in polycystic ovary syndrome.Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats Polycystic ovary syndrome and oocyte developmental competence.Implications of polycystic ovary syndrome on oocyte development.Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction.Anti-Müllerian hormone as a marker of ovarian reserve: an update.Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries.Androgen circle of polycystic ovary syndrome.The association between the oocyte pool and aneuploidy: a comparative study of the reproductive potential of young and aged mice.Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility.Dormancy and activation of human oocytes from primordial and primary follicles: molecular clues to oocyte regulation.Anti-Müllerian hormone inhibits activation and growth of bovine ovarian follicles in vitro and is localized to growing follicles.Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.Is polycystic ovary syndrome an exception for reproductive aging?Involvement of HSP10 during the ovarian follicular development of polycystic ovary syndrome: Study in both human ovaries and cultured mouse follicles.Predictors of IVF outcome: markers and protocols.Expression of TGF-beta superfamily growth factors, their receptors, the associated SMADs and antagonists in five isolated size-matched populations of pre-antral follicles from normal human ovaries.Psychotropic medication discussions in older adults' primary care office visits: So much to do, so little time.Effects of dehydroepiandrosterone on in vivo ovine follicular development.Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.

P2860

Q26829676-630017F9-71EE-428B-B972-414411FCF1FE Q26851230-738D917C-7070-4762-8FE6-E4CB66CAFFAD Q28390200-C67A31D4-44B9-4177-892F-F7D913ADAD5E Q30436274-4DEC831C-6691-4985-933B-7D8F7CC3E0B2 Q33646194-17162789-677D-4D3E-A3CA-439788A58AFF Q33786496-DB37E5B0-3893-405D-AE98-01D22449B627 Q33786859-E8322E6A-CBE2-4380-A36B-2AFCA5C6E655 Q34181497-9A02DF61-E7F0-472A-BA8D-0840C93B5EFC Q34398233-15678874-83BD-4EE3-B380-79AD2FE8AF67 Q34810982-E39E1537-1047-4FA4-8B62-570B3FA1AD33 Q34891866-0B623EE9-ACD3-4970-86AF-E78EF61FCBE1 Q35049012-786EB302-0645-4580-9E10-322A724A410D Q35050576-2AEC1504-02BD-499A-9FD9-1D12EEDD5762 Q35117692-F43E1A3D-705F-435D-99C4-AD34CA039DF9 Q35287911-BC72B159-9221-472D-8232-E2E7802C122C Q35484754-CCEC72B6-A446-4588-AC89-A0AFD6FAF1B4 Q35661747-C0CB48EF-9BA9-4DEE-9C68-40922F030D90 Q35901133-666421D5-EC12-47D1-96EB-AA1D5C1307C1 Q36035618-DC75E58F-EDFF-462D-8B08-85850A8FD812 Q36683316-535F587B-05A0-45B3-A572-B31D9774C38A Q36817513-700F8AF3-26DE-42FF-832E-1D49F517B692 Q37032912-4F58115C-5839-49A6-BC53-AF67D1B581D1 Q37052791-6F8EE1FE-7795-48F6-A804-A9259D70F474 Q37173546-175981E5-B44B-455E-B598-B72FBAEBFEB3 Q37346173-275854AB-6CCB-40C8-8E14-AE00BA372527 Q37368398-3AE3C812-E35B-4E90-B65E-10804B9F3E94 Q37412808-7912F6E1-00D9-49EF-BD07-B869734C2FEE Q37625661-F718F781-08ED-43EB-B25D-570123C25710 Q38038810-8B451122-016E-4D2F-A1EE-610BC9425013 Q38602009-5DB92527-A444-4B08-86CF-0776024BA885 Q38883773-1CCAF470-E06E-4FA7-B295-D81D93C8B3D3 Q38883826-B1196EB5-B567-48D5-935A-FA18B26D9051 Q42457179-700BDE5B-DB30-49DD-92B5-2D5E45334B88 Q43077067-0EA8A7FB-80D3-4E8E-BBF0-48A01E03C218 Q43244969-8F1D8BDA-68C2-4E33-91CC-00D20CF8EB14 Q43267059-503CDB7B-8CD1-40BD-8723-5B576E758390 Q43710307-A5CADBFC-8CDD-4857-B9F6-FED174D1D64D Q44379875-6F687F12-5D1D-4943-B5A3-E4447609B235 Q45166526-ED9E6053-85C0-4E9F-AA48-985CAF5442DD Q46288861-FB4E4D6A-1C57-4290-AD4D-AC64638CBB1C

P2860

Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.

http://www.wikidata.org/entity/Q33219958

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Anti-müllerian hormone protein ...... t in human polycystic ovaries.

@ast

Anti-müllerian hormone protein ...... t in human polycystic ovaries.

@en

type

label

Anti-müllerian hormone protein ...... t in human polycystic ovaries.

@ast

Anti-müllerian hormone protein ...... t in human polycystic ovaries.

@en

prefLabel

Anti-müllerian hormone protein ...... t in human polycystic ovaries.

@ast

Anti-müllerian hormone protein ...... t in human polycystic ovaries.

@en

P1433

Q33219958-692DA948-0B2A-41B2-ACC4-335945B9887B

P1476

Q33219958-E12256F1-0E64-4580-863F-780AC1C60CC5

P2093

Q33219958-4CE8D20B-15F8-4D05-8F80-D167E6EDECDD

Q33219958-51F7846B-F912-40BF-8965-F7210FE1BB96

Q33219958-6163919C-684C-46F0-95BB-16FCE8214CDA

Q33219958-83055D49-9466-47AB-8841-6274D5BF0564

Q33219958-87DCA586-18E0-44D3-B10E-575FC0E6FD5E

Q33219958-954C00F6-A94D-4E70-BB7B-081CA014426F

Q33219958-B3A40336-D381-4D03-BD7A-09E2D993434E

Q33219958-CE14C9D8-B76B-4AAB-9009-B347937AE21C

Q33219958-DF663E9C-1029-4BB8-8A3D-B07F54F05FBF

Q33219958-E566D752-6A69-453D-8B57-3E1F26040FED

P304

Q33219958-FBA4ECAA-14B6-44F6-815C-0C97BD04C8B3

P31

Q33219958-073F154F-7888-4630-B892-F6FA0BF79D55

P356

Q33219958-A0EA9368-E04D-4E6B-9770-91714440A89D

P407

Q33219958-20548553-56C5-4AF4-8B69-48B66EB7990D

P433

Q33219958-2C9F9F68-D791-45AA-A2C1-DB1C548E983B

P478

Q33219958-76CE4F85-0E13-4BB8-B3F1-9BEBD447CDD7

P577

Q33219958-59C56660-06F4-4D2A-A9BC-2952FDE3A44D

P5875

Q33219958-AED64D10-3CF0-4EA0-8E4D-061B33013A2C

P698

Q33219958-42A4EE4D-38A7-441A-A03E-D8CC5E989772

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Anti-müllerian hormone protein ...... t in human polycystic ovaries.

@en

P2093

Adrienne M Flanagan

http://www.w3.org/2001/XMLSchema#string

Axel P N Themmen

http://www.w3.org/2001/XMLSchema#string

Jaroslav Stark

http://www.w3.org/2001/XMLSchema#string

Jenny A Visser

http://www.w3.org/2001/XMLSchema#string

Kate Hardy

http://www.w3.org/2001/XMLSchema#string

Lisa J Webber

http://www.w3.org/2001/XMLSchema#string

Nigel P Groome

http://www.w3.org/2001/XMLSchema#string

Patricia Da Silva-Buttkus

http://www.w3.org/2001/XMLSchema#string

Sharron A Stubbs

http://www.w3.org/2001/XMLSchema#string

Stephen Franks

http://www.w3.org/2001/XMLSchema#string

P304

5536-5543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2005-0907

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7715169

http://www.w3.org/2001/XMLSchema#string

P698

16030171

http://www.w3.org/2001/XMLSchema#string